XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer
===========================================================================================================================================================================

* Kurt A Jenkins
* Miso Park
* Magali Pederzoli-Ribeil
* Ugur Eskiocak
* Parker Johnson
* Wilson Guzman
* Megan McLaughlin
* Deborah Moore-Lai
* Caitlin O’Toole
* Zhen Liu
* Benjamin Nicholson
* Veronica Flesch
* Huawei Qiu
* Tim Clackson
* Ronan C O’Hagan
* Ulrich Rodeck
* Margaret Karow
* Jennifer O’Neil
* John C Williams